2022-12-01 2023-11-30 false Capium Accounts Production 1.1 11052680 bus:AbridgedAccounts 2022-12-01 2023-11-30 11052680 bus:FRS102 2022-12-01 2023-11-30 11052680 bus:AuditExemptWithAccountantsReport 2022-12-01 2023-11-30 11052680 bus:SmallCompaniesRegimeForAccounts 2022-12-01 2023-11-30 11052680 bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 11052680 2022-12-01 2023-11-30 11052680 2023-11-30 11052680 bus:RegisteredOffice 2022-12-01 2023-11-30 11052680 core:WithinOneYear 2023-11-30 11052680 core:AfterOneYear 2023-11-30 11052680 bus:Director1 2022-12-01 2023-11-30 11052680 bus:Director1 2023-11-30 11052680 bus:Director1 2021-12-01 2022-11-30 11052680 2021-12-01 11052680 bus:LeadAgentIfApplicable 2022-12-01 2023-11-30 11052680 2021-12-01 2022-11-30 11052680 2022-11-30 11052680 core:WithinOneYear 2022-11-30 11052680 core:AfterOneYear 2022-11-30 11052680 bus:EntityAccountantsOrAuditors 2021-12-01 2022-11-30 11052680 bus:OrdinaryShareClass1 2022-12-01 2023-11-30 11052680 bus:OrdinaryShareClass1 2023-11-30 11052680 bus:OrdinaryShareClass1 2021-12-01 2022-11-30 11052680 bus:OrdinaryShareClass1 2022-11-30 11052680 core:CostValuation core:Non-currentFinancialInstruments 2023-11-30 11052680 core:CostValuation core:Non-currentFinancialInstruments 2022-11-30 11052680 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2023-11-30 11052680 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2023-11-30 11052680 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2023-11-30 11052680 core:Non-currentFinancialInstruments 2023-11-30 11052680 core:Non-currentFinancialInstruments 2022-11-30 11052680 core:ShareCapital 2023-11-30 11052680 core:ShareCapital 2022-11-30 11052680 core:RetainedEarningsAccumulatedLosses 2023-11-30 11052680 core:RetainedEarningsAccumulatedLosses 2022-11-30 11052680 dpl:Item1 2022-12-01 11052680 dpl:Item1 2023-11-30 11052680 dpl:Item1 2021-12-01 11052680 dpl:Item1 2022-11-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 11052680
England and Wales

 

 

 

FHL PHARMA LIMITED


Abridged Accounts
 


Period of accounts

Start date: 01 December 2022

End date: 30 November 2023
Accountants report You consider that the company is exempt from an audit for the year ended 30 November 2023 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year. In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Balance Sheet and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us. We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts. 



....................................................

Akhter's Limited Accountants and Business Advisors

64 Castle Boulevard
Nottingham
NG7 1FN
19 September 2024
1
 
 
Notes
 
2023
£
  2022
£
Current assets      
Debtors: amounts falling due within one year 2   
Debtors: amounts falling due after one year 5,259    5,259 
Cash at bank and in hand 3,222    6,099 
8,483    11,358 
Creditors: amount falling due within one year (3,088)   (3,376)
Net current assets 5,395    7,982 
 
Total assets less current liabilities 5,395    7,982 
Creditors: amount falling due after more than one year (5,056)   (7,056)
Net assets 339    926 
 

Capital and reserves
     
Called up share capital 3 100    100 
Profit and loss account 239    826 
Shareholders' funds 339    926 
 


For the year ended 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006 the profit and loss account has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 19 September 2024 and were signed by:


-------------------------------
Mrs Farzaneh Hajipour Latarany
Director
2
General Information
FHL Pharma Limited is a private company, limited by shares, registered in England and Wales, registration number 11052680, registration address 64 Castle Boulevard, Nottingham, NG7 1FN.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of any trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
2.

Average number of employees

Average number of employees during the year was 1 (2022 : 1).
3.

Share Capital

Allotted, called up and fully paid
2023
£
  2022
£
100 Ordinary shares of £1.00 each 100    100 
100    100 

3